| Bioactivity | 3-Hydroxyflunitrazepam is the major metabolite of Flunitrazepam (FNTZ), generated via 3-hydroxylation by CYP3A4 (Km = 286 μM), and represents the dominant metabolic pathway (>80%) in liver microsomes. Its formation is significantly inhibited by CYP3A4 inhibitors such as Ketoconazole (HY-B0105) (IC50 = 0.11 μM) and Ritonavir (HY-90001) (IC50 = 0.041 μM), indicating a strong dependence on CYP3A4 activity and potential drug interactions[1]. |
| CAS | 67739-71-3 |
| Formula | C16H12FN3O4 |
| Molar Mass | 329.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hesse LM, et al. CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Drug Metab Dispos. 2001 Feb;29(2):133-40. |
3-Hydroxyflunitrazepam
CAS: 67739-71-3 F: C16H12FN3O4 W: 329.28
3-Hydroxyflunitrazepam is the major metabolite of Flunitrazepam (FNTZ), generated via 3-hydroxylation by CYP3A4 (Km = 28
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.